Cardinal Health raises fiscal 2026 EPS outlook as second-quarter revenue rises 19%
Cardinal Health reported second-quarter fiscal 2026 revenue of $65.6 billion, up 19%, and GAAP diluted EPS of $1.97, up 19%. The company raised its fiscal 2026 non-GAAP diluted EPS guidance to $10.15 to $10.35, which matters to shareholders because it reflects higher expected earnings for the full year.
Key points
- Revenue rose 19% to $65.6 billion; GAAP operating earnings rose 29% to $707 million.
- Non-GAAP diluted EPS rose 36% to $2.63; GAAP diluted EPS rose 19% to $1.97.
- Fiscal 2026 non-GAAP diluted EPS guidance raised to $10.15 to $10.35.
- Year-to-date share repurchases reached $750 million; net interest expense rose to $88 million from $35 million.
The filing
Written by AI (Anthropic Claude, claude-haiku-5-5) on Nov 8, 2026, 1:42 AM ET, from the text of the filing and its press-release exhibits only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on February 05, 2026.
Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.